Jason Slakter

2016

In 2016, Jason Slakter earned a total compensation of $2M as Chief Executive Officer at Ohr Pharmaceutical, a 221% increase compared to previous year.

Compensation breakdown

Bonus$175,000
Salary$200,000
Stock Awards$1,583,618
Other$195
Total$1,958,813

Slakter received $1.6M in stock awards, accounting for 81% of the total pay in 2016.

Slakter also received $175K in bonus, $200K in salary and $195 in other compensation.

Rankings

In 2016, Jason Slakter's compensation ranked 4,974th out of 14,075 executives tracked by ExecPay. In other words, Slakter earned more than 64.7% of executives.

ClassificationRankingPercentile
All
4,974
out of 14,075
65th
Division
Manufacturing
1,777
out of 5,486
68th
Major group
Chemicals And Allied Products
564
out of 1,900
70th
Industry group
Drugs
420
out of 1,543
73rd
Industry
Pharmaceutical Preparations
335
out of 1,173
71st
Source: SEC filing on September 7, 2018.

Slakter's colleagues

We found two more compensation records of executives who worked with Jason Slakter at Ohr Pharmaceutical in 2016.

2016

Sam Backenroth

Ohr Pharmaceutical

Chief Financial Officer

2016

Avner Ingerman

Ohr Pharmaceutical

Former Chief Clinical Officer

You may also like